Neuropace Stock Investor Sentiment

NPCE Stock  USD 9.50  0.15  1.60%   
About 52% of Neuropace's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Neuropace stock suggests that some investors are interested at this time. The current market sentiment, together with Neuropace's historical and current headlines, can help investors time the market. In addition, many technical investors use Neuropace stock news signals to limit their universe of possible portfolio assets.
a day ago at news.google.com         
Acquisition by Lacob Joseph of 2505 shares of Neuropace at 4.49 subject to Rule 16b-3
Google News at Macroaxis
few days ago at news.google.com         
What drives NeuroPace Inc. stock price - Breakthrough stock performance - Jammu Links News
Google News at Macroaxis
few days ago at www.macroaxis.com         
Acquisition by Kumar Rakhi of 1247 shares of Neuropace at 12.02 subject to Rule 16b-3
Macroaxis News
over a week ago at zacks.com         
AngioDynamics Reports Q4 Loss, Tops Revenue Estimates
zacks News
over a week ago at www.macroaxis.com         
Acquisition by Geiger Uri of 2337 shares of Neuropace at 4.49 subject to Rule 16b-3
Macroaxis News
over two weeks ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NP...
Macroaxis News: globenewswire.com
over two weeks ago at gurufocus.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...
Gurufocus Stories at Macroaxis
over two weeks ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NP...
Macroaxis News: globenewswire.com
over two weeks ago at gurufocus.com         
INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
NeuroPace Inc Trading 3.92 percent Higher on Jun 30
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
NeuroPace - Volatile, Uncertain, But Promising - Seeking Alpha
Google News at Macroaxis
over three weeks ago at globenewswire.com         
INVESTOR ALERT Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of NeuroPace, Inc. - NPC...
Macroaxis News: globenewswire.com
over three weeks ago at gurufocus.com         
INVESTOR ALERT Pomerantz Law Firm Investigates ClaimsOn Behalf
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
NeuroPace, Inc. Receives 15.50 Average PT from Analysts
news
over three weeks ago at gurufocus.com         
NeuroPace Inc Trading Down 3.93 percent on Jun 27
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.

Neuropace Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Neuropace Stock analysis

When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk